However, our case did not show any mutations in AKT1, HRAS or PIK3CA. Although the number of reported cases is very small, the frequency of HRAS mutations in pulmonary EMC is 75% (3/4 cases). This evidence concerns the gene AKT1 and extraskeletal myxoid chondrosarcoma.